Curist

New York, United States Founded: 2018 • Age: 8 yrs
Generic drugs are manufactured by Curist in the pharmaceutical sector.
Annual revenue - Latest available
Total funding $707,500 1 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Curist

Curist is a company based in New York (United States) founded in 2018 by Ethan Lauf Goldstein. Curist has raised $707.5 thousand across 1 funding round.

  • Headquarter New York, United States
  • Founders Ethan Lauf Goldstein
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $707.5 K (USD)

    in 1 rounds

  • Latest Funding Round
    $707.5 K (USD), Seed

    Sep 09, 2019

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Curist

Headcount 1-10
Employee Profiles 1
Employee Profiles
People
Ethan Lauf Goldstein
Founder & CEO

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Curist

Curist has successfully raised a total of $707.5K through 1 strategic funding round. The most recent funding activity was a Seed round of $707.5 thousand completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Curist

Investments
Premium access

Investment portfolio details for Curist

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Curist

Premium access

Detailed financials for Curist

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Curist Comparisons

Curist Primary company
Description
Generic drugs are manufactured by Curist in the pharmaceutic...
Location
New York, United States
Founded Year
2018
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Curist

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Curist

Premium access

Detailed competitors of Curist

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Curist

Premium access

Complete news archive for Curist

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Curist

Curist was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Curist is headquartered in New York, United States. It is registered at New York, New York, United States.

Ethan Lauf Goldstein is the current CEO of Curist. They have also founded this company.

Curist is a funded company, having raised a total of $707.5K across 1 funding round to date.

Curist was established in 2018 in New York, United States, as a manufacturer of generic drugs. Operations are centered on producing affordable pharmaceutical alternatives, with a focus on relief-oriented products accessible via the domain curistrelief.com. Leadership is provided by founder and CEO Ethan Lauf Goldstein. The company functions within the generics industry, serving markets through standard distribution channels in the U.S.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available